Skip to main content
Account

Table 1 Baseline characteristics of individuals by quartiles of TyG index

From: Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study

 

Quartile 1

(5.75–8.06)

Quartile 2

(8.07–8.49)

Quartile 3

(8.50–8.94)

Quartile 4

(8.95–13.25)

P value

N

6797

7012

6879

6954

 

Age, years

38.0 ± 17.7

46.9 ± 19.6

50.8 ± 18.6

53.7 ± 16.8

< 0.0001

Male, n (%)

2887 (39.8)

3435 (48.1)

3592 (52.2)

3956 (58.1)

< 0.0001

Ethnicity, n (%)

    

< 0.0001

 Non-Hispanic White

2492 (63.1)

2987 (67.7)

3170 (70.1)

3244 (71.0)

 

 Non-Hispanic Black

2248 (18.0)

1651 (12.3)

1071 (7.7)

820 (6.0)

 

 Hispanic

1462 (12.3)

1774 (13.4)

2014 (15.3)

2282 (16.1)

 

 Other

595 (6.6)

600 (6.7)

624 (6.9)

608 (6.9)

 

Systolic blood pressure, mmHg

118 ± 18

124 ± 20

127 ± 20

131 ± 20

< 0.0001

Body mass index, kg/m2

31.3 ± 6.7

29.9 ± 6.8

28.2 ± 6.5

26.4 ± 6.0

< 0.0001

Smoking status, n (%)

    

< 0.0001

 Never smoker

4636 (64.1)

4134 (56.4)

3706 (51.6)

3373 (47.3)

 

 Former smoker

1026 (17.5)

1477 (22.3)

1765 (26.8)

2042 (29.5)

 

 Current smoker

1135 (18.5)

1401 (21.3)

1408 (21.6)

1539 (23.3)

 

Alcohol consumption, n (%)

    

0.002

 Never

3008 (35.8)

2907 (35.7)

2823 (35.6)

2872 (37.3)

 

 Less than once a week

3646 (61.4)

3888 (59.6)

3830 (60.1)

3878 (58.7)

 

 More than once a week

143 (2.9)

217 (4.7)

226 (4.3)

204 (3.9)

 

Total cholesterol, mmol/L

4.49 ± 0.90

4.89 ± 0.98

5.14 ± 1.02

5.45 ± 1.23

< 0.0001

HDL cholesterol, mmol/L

1.59 ± 0.42

1.45 ± 0.40

1.32 ± 0.35

1.13 ± 0.30

< 0.0001

LDL cholesterol, mmol/L

2.60 ± 0.77

2.99 ± 0.87

3.18 ± 0.93

3.14 ± 1.02

< 0.0001

Triglycerides, mmol/L

0.62 (0.52–0.72)

0.97 (0.87–1.09)

1.42 (1.26–1.60)

2.30 (1.92–2.99)

< 0.0001

Glucose, mmol/L

4.83 ± 0.51

5.14 ± 0.68

5.44 ± 0.96

6.86 ± 3.05

 

Albumin, g/L

42.9 ± 3.5

42.4 ± 3.4

42.5 ± 3.4

42.8 ± 3.4

< 0.0001

eGFR, mL/min

106.4 ± 24.1

97.9 ± 25.7

94.7 ± 25.5

92.3 ± 25.5

< 0.0001

Diabetes mellitus, n(%)

608 (7.6)

855 (9.9)

1330 (15.3)

2765 (33.6)

< 0.0001

ASCVD, n(%)

260 (3.2)

495 (5.4)

669 (7.7)

899 (11.3)

< 0.0001

COPD, n (%)

244 (4.0)

386 (5.9)

430 (6.3)

559 (8.5)

< 0.0001

Cancer, n (%)

344 (5.8)

550 (8.0)

649 (9.4)

731 (10.9)

< 0.0001

Chronic heart failure, n (%)

84 (1.0)

185 (1.8)

223 (2.3)

337 (4.1)

< 0.0001

Chronic renal disease (eGFR < 60 mL/min), n (%)

246 (2.4)

508 (4.9)

646 (6.6)

762 (8.4)

< 0.0001

Statin use, n (%)

428 (5.7)

900 (11.9)

1184 (16.1)

1671 (23.2)

< 0.0001

Insulin or antihyperglycemic agents

151 (1.5)

315 (2.8)

578 (5.7)

1568 (18.5)

< 0.0001

Education level, n (%)

    

< 0.0001

 Under high school

1178 (12.8)

1695 (15.8)

1902 (18.9)

2262 (21.2)

 

 High school graduate

1230 (19.7)

1512 (23.5)

1566 (24.5)

1623 (26.5)

 

 Above high school/unknown

4389 (67.5)

3805 (60.8)

3411 (56.5)

3069 (52.3)

 

Marital status, n (%)

    

< 0.0001

 Married/cohabiting

3153 (55.1)

3826 (60.7)

4092 (62.7)

4271 (64.8)

 

 Separated/divorced/widowed

975 (13.3)

1392 (16.4)

1485 (18.6)

1724 (21.3)

 

 Never married/unknown

2669 (31.6)

1794 (23.0)

1302 (18.7)

959 (13.9)

 

Poverty income ratio (PIR)

2.1 (1.1−4.0)

2.1 (1.1–4.1)

2.1 (1.1−4.0)

1.9 (1.1–3.6)

0.002

All-cause mortality

524 (5.5)

1005 (10.0)

1158 (12.1)

1387 (15.9)

< 0.0001

Cardiovascular mortality

144 (1.3)

318 (3.0)

367 (3.6)

467 (5.1)

< 0.0001

Non-cardiovascular mortality

380 (4.2)

687 (7.0)

791 (8.5)

920 (10.8)

< 0.0001

  1. Continuous variables are presented as means (standard deviations) or medians (interquartile ranges), and categorical variables are presented as n (%). N, number of subjects; %, weighted percentage. PIR is calculated by dividing family income by family size, year, and geographic location, as measured by the Department of Health and Human Services. HDL high-density lipoprotein, LDL low-density lipoprotein, ASCVD atherosclerotic cardiovascular disease, COPD chronic obstructive pulmonary disease